CGTX
Cognition Therapeutics Inc
0.9366$
-0.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.0% | 97.3% | 97.7% | 97.6% | 97.3% | 97.8% | 97.3% | 97.1% | 98.8% | 99.2% | 99.1% | 98.5% | |
| 85.0% | 85.1% | 89.2% | 83.0% | 79.8% | 82.7% | 69.9% | 54.7% | 91.8% | 76.5% | 86.1% | 87.4% | |
| 85.0% | 85.1% | 89.2% | 83.0% | 79.8% | 82.7% | 69.9% | 54.7% | 91.8% | 76.5% | 86.1% | 87.4% | |
| 4.2% | 3.6% | 2.2% | 9.0% | 12.2% | 8.9% | 20.3% | 32.0% | 4.4% | 20.5% | 10.1% | 7.6% | |
| 25.4% | 30.4% | 25.7% | 33.1% | 47.5% | 38.0% | 47.8% | 64.2% | 15.8% | 29.2% | 17.2% | 15.1% | |
| 21.2% | 28.9% | 24.5% | 31.8% | 46.1% | 36.9% | 46.6% | 63.0% | 15.3% | 28.8% | 16.7% | 14.0% | |
| 0.4% | 2.0% | 1.4% | 1.1% | 0.7% | 1.6% | 1.5% | 1.2% | 0.4% | 0.9% | 0.8% | 0.2% | |
| 7.4% | 10.5% | 6.8% | 8.8% | 6.9% | 6.6% | 7.7% | 3.9% | 1.9% | 2.3% | 10.7% | 1.7% | |
| 74.6% | 69.6% | 74.3% | 66.9% | 52.5% | 62.0% | 52.2% | 35.8% | 84.2% | 70.8% | 82.8% | 84.9% | |
| -343.2% | -401.5% | -387.0% | -457.9% | -606.7% | -579.3% | -781.4% | -970.2% | -450.1% | -410.5% | -562.3% | -532.6% | |
| 78.3% | 87.5% | 86.8% | 116.6% | 146.6% | 153.6% | 263.1% | 324.6% | 179.6% | 183.7% | 246.8% | 233.0% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.